Why is Aarti Pharma falling/rising?

As of 25-Sep, Aarti Pharmalabs Ltd is experiencing a decline in its stock price, currently at 842.95, reflecting a decrease of 15.1 points or 1.76%. The stock has underperformed its sector by 0.9% today and has been on a downward trend for the last four days, accumulating a total loss of 9.39% during this period. Despite a strong year-to-date return of 22.66% and a one-year return of 35.04%, the stock's recent performance has been negatively impacted by a significant drop in investor participation, with delivery volume falling by 89.14% against the five-day average. The stock is currently trading above its 200-day moving average but below its shorter-term moving averages, indicating mixed signals in terms of momentum.
In the broader market context, Aarti Pharmalabs has outperformed the benchmark, as the Sensex has declined by 2.23% over the past week and 4.71% over the past year, while Aarti has shown resilience with a one-year return of 35.04%. However, the recent consecutive falls may reflect market sentiment shifting despite the company's strong fundamentals, including a low Debt to EBITDA ratio and attractive valuation metrics. The stock's ability to generate profits, which have increased by 18.3% over the past year, suggests underlying strength, yet the current market dynamics and declining trading volumes are contributing to its recent price decline.